NCT06064097 2026-03-19
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
National Cancer Institute (NCI)
Phase 2 Recruiting
Clinical Trials
4 trialsNCT06980038 2026-03-19
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT06870435 2025-03-11
Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas
Sun Yat-sen University
Phase NA Recruiting
NCT04085900 2023-07-13
Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City
Zhongshan People's Hospital, Guangdong, China
Recruiting